Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-5-1
pubmed:abstractText
We previously reported that activation of nicotinic receptors causes an enhancement in amphetamine-stimulated release of dopamine via its transporter from slices of prefrontal cortex, but no such enhancement of release from slices of nucleus accumbens or striatum. The nicotinic receptors mediating the enhancement most likely contain alpha4 and beta2 subunits based upon pharmacological characterization. In this study, we sought to characterize the second messenger systems associated with the nicotine-mediated response. Sodium channel involvement was confirmed by the observation that tetrodotoxin blocked nicotine-mediated enhancement, whereas veratridine or elevated K(+) mimicked the enhancement seen with nicotine. Inclusion of EGTA blocked nicotine-mediated enhancement, suggesting that, even though no exogenous Ca(2+) was added, endogenous stores were required for the enhancement. The enhancement by nicotine was also abolished by the L-type voltage-dependent calcium channel (VDCC) antagonist nitrendipine, but not by the N-type VDCC antagonist omega-conotoxin GVIA. Finally, inhibition of protein kinase C also abolished the nicotine-mediated enhancement of amphetamine-stimulated dopamine release, whereas inhibitors of Ca(2+)/calmodulin kinase II did not. These findings establish that nicotine can exert selective effects on dopamine transporter activity in prefrontal cortex, an area involved in cognition and learning.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids, http://linkedlifedata.com/resource/pubmed/chemical/Amphetamine, http://linkedlifedata.com/resource/pubmed/chemical/Benzophenanthridines, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Plasma Membrane Transport..., http://linkedlifedata.com/resource/pubmed/chemical/Egtazic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Maleimides, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nicotine, http://linkedlifedata.com/resource/pubmed/chemical/Phenanthridines, http://linkedlifedata.com/resource/pubmed/chemical/Potassium, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Nicotinic, http://linkedlifedata.com/resource/pubmed/chemical/Sodium Channels, http://linkedlifedata.com/resource/pubmed/chemical/Staurosporine, http://linkedlifedata.com/resource/pubmed/chemical/Tetrodotoxin, http://linkedlifedata.com/resource/pubmed/chemical/Tritium, http://linkedlifedata.com/resource/pubmed/chemical/Veratridine, http://linkedlifedata.com/resource/pubmed/chemical/bisindolylmaleimide I, http://linkedlifedata.com/resource/pubmed/chemical/chelerythrine, http://linkedlifedata.com/resource/pubmed/chemical/omega-Conotoxin GVIA
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
839-48
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11331413-Alkaloids, pubmed-meshheading:11331413-Amphetamine, pubmed-meshheading:11331413-Animals, pubmed-meshheading:11331413-Benzophenanthridines, pubmed-meshheading:11331413-Calcium, pubmed-meshheading:11331413-Calcium Channel Blockers, pubmed-meshheading:11331413-Carrier Proteins, pubmed-meshheading:11331413-Dopamine, pubmed-meshheading:11331413-Dopamine Plasma Membrane Transport Proteins, pubmed-meshheading:11331413-Egtazic Acid, pubmed-meshheading:11331413-Enzyme Inhibitors, pubmed-meshheading:11331413-Indoles, pubmed-meshheading:11331413-Male, pubmed-meshheading:11331413-Maleimides, pubmed-meshheading:11331413-Membrane Glycoproteins, pubmed-meshheading:11331413-Membrane Transport Proteins, pubmed-meshheading:11331413-Nerve Tissue Proteins, pubmed-meshheading:11331413-Nicotine, pubmed-meshheading:11331413-Phenanthridines, pubmed-meshheading:11331413-Potassium, pubmed-meshheading:11331413-Protein Kinase C, pubmed-meshheading:11331413-Rats, pubmed-meshheading:11331413-Rats, Sprague-Dawley, pubmed-meshheading:11331413-Receptors, Nicotinic, pubmed-meshheading:11331413-Second Messenger Systems, pubmed-meshheading:11331413-Sodium Channels, pubmed-meshheading:11331413-Staurosporine, pubmed-meshheading:11331413-Tetrodotoxin, pubmed-meshheading:11331413-Tritium, pubmed-meshheading:11331413-Veratridine, pubmed-meshheading:11331413-omega-Conotoxin GVIA
pubmed:year
2001
pubmed:articleTitle
Protein kinase C regulation of dopamine transporter initiated by nicotinic receptor activation in slices of rat prefrontal cortex.
pubmed:affiliation
Department of Pharmacology, The George Washington University Medical Center, Washington DC 20037, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't